Quality of life and symptomatology in benign prostate hyperplasia in active Spanish population;Calidad de vida y sintomatología en la hiperplasia prostática benigna en población activa española

Medicina Clinica

Volumn 114, Issue SUPPL. 3, 2000, Pages 81-89

  Acebo, Alfonso Gómez ^a   Vallejo, José María Rodríguez ^a   Mora, Vicente I Rodríguez ^a   Alcázar, Inés García ^a  

^a MSD   (Spain)

Author keywords

Benign prostatic hypertrophy; Cross sectional studies; Quality of life; Questionnaires; Severity of illness index

Indexed keywords

AGED; ARTICLE; HUMAN; MALE; MIDDLE AGED; PROSTATE HYPERTROPHY; SICKNESS IMPACT PROFILE; SPAIN;

AGED; HUMANS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; SICKNESS IMPACT PROFILE; SPAIN;

EID: 0033640962     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Barry MJ, Adolfsson J, Batista JE, Bosch JLHR, Corica A, Bonovan J et al. Measuring the symptoms and health impact of benign prostatic hyperplasia and its treatments. Proceedings 4th International Consultation on B.P.H. 1998, 265-321.
2. Chicharro Molero JA, Burgos Rodríguez. Epidemiología de la hiperplasia benigna de próstata. Medicine 1997 (Supl); 7: 3-8.
3. th International Consultation on B.P.H. 1998, 669-684.
4. th International Consultation on B.P.H. 1998, 179-264.
5. Bosch X. Spanish lives long and healthy lives. Lancet 1998; 352: 1610.
6. IMS HEALTH, Global Services Report - (1993 and 1998).
7. Chicharro Molero JA, Burgos Rodríguez R. Epidemiología de la hiperplasia benigna de próstata: definición de enfermedad. Rev Clin Esp 1999; 199; 12-18.
8. Oesterling JE. Benign prostatic hyperplasia: a review of its histogenesis and natural history. Prostate (Supl) 1996; 6: 67-73.
9. McConnell JD, Bruskewitz R, Walsh P, Andriole G, Lieber M, Holtgrewe HL et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group (see comments). N Engl J Med 1998; 338(9): 557-563.
10. Mazketli W, Merenciano F, Amat M, Romero P. Retención urinaria completa. Revisión del tratamiento. Urod A 1997; 3: 131-134.
11. Chicharro-Molero JA, Burgos-Rodríguez R, Sánchez-Cruz JJ, Del Rosal Samaniego JM, Rodero García P, Rodríguez Vallejo JM. Prevalence of benign prostatic hyperplasia in Spanish men 40 years old or older. J Urol 1998; 159: 878-882.
12. Vela Navarrete R et al. Prostatismo en España: perfil clínico del paciente solicitando tratamiento al urólogo. Actas Urol Esp 1998; 5 (Supl 22): 24.
13. García Alcázar I, Rodríguez-Mora VI, Rodríguez Vallejo JM, Gómez Acebo A. Investigación de patología prostática en una población laboral. IV Congreso Nacional de Medicina del Trabajo 1997; 2-10.
14. Vela Navarrete R, Martín Moreno JM, Damián Moreno J et al. Validación cultural y lingüística en castellano del baremo internacional de sintomatología prostática. Actas Urol Esp 1994; 18: 841-847.
15. a ed.), 1997; 131-155.
16. Resel Estévez L, Rodríguez Vallejo JM, Conejero Sugrañes J, Jiménez Cruz F, Rioja Sanz LA, Vela Navarrete R, et al. Estudio poblacional comparativo mediante encuesta como método de evaluación de las modificaciones sobre la patología prostática. Actas Urol Esp 1999; 23(8): 657-669.
17. Hunter DJ, Berra-Unamuno A, Martín Gordo. Prevalence of urinary symptoms and other urological conditions in Spanish men 50 years old or older. J Urol 1996; 155: 1965-1970.
18. Kay L, Stigsby B, Brasso K, Mortensen SO, Munkgaard S. Lower urinary tract symptoms. Scand J Urol Nephrol 1999; 33: 94-99.
19. Homma Y, Kawabe K, Tsukamoto T, Yamanaka H, Okada K, Okagima E et al. Epidemiologic survey of lower urinary tract symptoms in Asia and Australia using the International Prostate Symptom Score. Int J Urol 1997; 4: 40-46.
20. Trueman P, Hood SC, Nayak USL, Mracek MMF. Prevalence of lower urinary tract symptoms and self-reported diagnosed «benign prostatic hyperplasia», and their effect on quality of life in a community-based survey of men in the UK. BJU International 1999; 83: 410-415.
21. Sagnier PP, Girman CJ, Garraway M, Kumamoto Y, Lieber M, Richard F et al. International comparison of the community prevalence of symptoms of prostatism in four countries. Eur Urol 1996; 29: 15-20.